JSKN033 in Chinese Subjects with Advanced Malignant Tumors
Clinical trial NCT06770881 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06770881
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-15
- Primary completion
- 2026-12-31
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.